Focused on the research and development and production of resin materials and resin end products - Hebei Lijiang
-
AboutHebei Lijiang Biotechnology Co., Ltd. is a new material manufacturer specializing in the production of functional special ion exchange resins and disposable blood perfusion devices. It is a modern high-tech enterprise integrating the research and development, production, sales, and service of resin materials and resin end products. The company was established in April 2014 with a registered capital of 52 million yuan. It plans to cover an area of 267 acres and is located in the High-tech Industrial Park of Weixian County, Hebei Province—New Material Demonstration Park. The total investment is 510 million yuan. It is a council member unit of the Ion Exchange Resin Branch of the China Membrane Industry Association.
-
Product
-
BlogsThe company will focus on the high-end market, with the purpose of serving society, solidly carrying out technological innovation and product promotion, continuously improving the development and expansion of ion exchange resin products in emerging application fields, thereby promoting the upgrading and development of related industries.
-
Company AlbumThe current phase of construction has been fully completed and put into operation, featuring a comprehensive workshop with 42 production lines for functional ion exchange resins with an annual output of 16,800 tons and a production capacity of 30,000 tons, a wastewater treatment plant with an annual treatment capacity of 403,000 tons, and a workshop producing 5,000 tons of medical-grade magnesium sulfate annually. Trial production began in July 2016, with official production starting in January 2017.
Company Introduction
Hebei Lijiang Biotechnology Co., Ltd.
Hebei Lijiang Biotechnology Co., Ltd. is a new material manufacturer mainly producing functional special ion exchange resins and disposable blood perfusion devices. It is a modern high-tech enterprise integrating R&D, production, sales, and service of resin materials and resin end products.
The company was established in April 2014 with a registered capital of 52 million yuan, planning an area of 267 acres, located in the High-tech Industrial Park of Weixian County, Hebei Province - New Material Demonstration Park, with a total investment of 510 million yuan RMB. It is a council member unit of the Ion Exchange Resin Branch of the China Membrane Industry Association.
The company’s overall plan is divided into two phases. The first phase has been fully completed and put into production, with one comprehensive workshop having 42 production lines for functional ion exchange resins with an annual output of 16,800 tons and a production capacity of 30,000 tons, one wastewater treatment plant with an annual treatment capacity of 403,000 tons, and one medical-grade magnesium sulfate workshop with an annual output of 5,000 tons. Trial production began in July 2016, and formal production started in January 2017. The second phase, a special anion exchange resin production workshop with an annual output of 6,000 tons, is currently under renovation and debugging and has officially started operation. The blood perfusion device production workshop is planned to start construction in October 2018.
The company is committed to producing high-quality industrial grade, food grade, pharmaceutical grade, and nuclear grade resins. Product application fields cover water pollution control, high purity water treatment, Chinese and Western medicine extraction, blood perfusion, new agricultural planting, new material nano-coatings, rare precious metal refining, etc. The production base has passed ISO9001 management certification and is currently one of the largest resin manufacturers in China with a wide variety of products, selling well domestically and exporting to Europe, America, Japan, Russia, and Southeast Asia.
The company always adheres to the development strategy of integrating production, education, and research, forming an efficient and innovative R&D team. Professor Shi Zuoqing from the Chemistry Department of Nankai University, a member of the National Chemistry Division, serves as the company's honorary chairman and chief technical advisor, continuously carrying out technical exchanges and cooperation with Nankai University, Nanjing University, University of Science and Technology of China, and other research institutions and related R&D organizations, forming a broad technical guarantee and R&D source.
Currently, Lijiang has established one of the largest ion exchange resin engineering technology research centers in North China. As a Hebei Province high-tech enterprise, intelligence introduction workstation, Xingtai high-end talent entrepreneurship base, and Xingtai Weixian innovation incubation park platform, it has attracted many scientific and technological talents in the ion exchange resin and medical device industries, safeguarding Lijiang's technology application and development.
Lijiang Bio not only inherits the high-quality tradition of related industry enterprises but also gains strong vitality through market-oriented operations. The company will focus on high-end, serve society as its purpose, solidly carry out technological innovation and product promotion, continuously improve product development and expansion of ion exchange resins in emerging application fields, thereby promoting the upgrading and development of related industries.